| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0.001 | 0.949 | 5 Hydroxytryptamine release stimulant | 0.888 0.002 DBMET00800 0.888 0.002 DBMET00458 | ||
| 0.479 | 0.032 | 0.611 | Vasodilator, peripheral | 0.611 0.015 DBMET00800 0.611 0.015 DBMET00458 | DBMET00458 | |
| 0.482 | 0.038 | 0.482 | Immunosuppressant | 0.466 0.043 DBMET00800 0.466 0.043 DBMET00458 | ||
| 0.442 | 0.032 | 0.659 | Spasmolytic | 0.659 0.008 DBMET00800 0.659 0.008 DBMET00458 | DBMET00458 | |
| 0.413 | 0.004 | 0.413 | Histone deacetylase stimulant | |||
| 0.413 | 0.004 | 0.413 | Histone deacetylase SIRT1 stimulant | |||
| 0.493 | 0.09 | 0.493 | Antiinflammatory | 0.396 0.142 DBMET00800 0.396 0.142 DBMET00458 | ||
| 0.432 | 0.06 | 0.432 | 5 Hydroxytryptamine release inhibitor | 0.386 0.087 DBMET00800 0.386 0.087 DBMET00458 | ||
| 0.383 | 0.025 | 0.383 | Sigma receptor agonist | 0.367 0.027 DBMET00800 0.367 0.027 DBMET00458 | ||
| 0.385 | 0.084 | 0.411 | Antibacterial | 0.411 0.072 DBMET00800 0.411 0.072 DBMET00458 | DBMET00458 | |
| 0.325 | 0.045 | 0.325 | Free radical scavenger | |||
| 0.351 | 0.076 | 0.356 | Transcription factor NF kappa B inhibitor | 0.356 0.075 DBMET00800 0.356 0.075 DBMET00458 | DBMET00458 | |
| 0.307 | 0.05 | 0.362 | Tumour necrosis factor alpha release inhibitor | 0.362 0.035 DBMET00800 0.362 0.035 DBMET00458 | DBMET00458 | |
| 0.312 | 0.066 | 0.338 | Interleukin 2 agonist | 0.338 0.051 DBMET00800 0.338 0.051 DBMET00458 | DBMET00458 | |
| 0.277 | 0.046 | 0.277 | Tyrosine 3 hydroxylase inhibitor | 0.241 0.077 DBMET00800 0.241 0.077 DBMET00458 | ||
| 0.263 | 0.045 | 0.417 | Anesthetic general | 0.417 0.014 DBMET00800 0.417 0.014 DBMET00458 | DBMET00458 | |
| 0.255 | 0.04 | 0.255 | P-glycoprotein inhibitor | 0.251 0.041 DBMET00800 0.251 0.041 DBMET00458 | ||
| 0.264 | 0.06 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.205 0.125 DBMET00800 0.205 0.125 DBMET00458 | ||
| 0.255 | 0.057 | 0.36 | Psychostimulant | 0.36 0.029 DBMET00800 0.36 0.029 DBMET00458 | DBMET00458 | |
| 0.205 | 0.008 | 0.208 | Prolactin inhibitor | 0.208 0.008 DBMET00800 0.208 0.008 DBMET00458 | DBMET00458 | |
| 0.267 | 0.075 | 0.267 | Antioxidant | 0.185 0.127 DBMET00800 0.185 0.127 DBMET00458 | ||
| 0.189 | 0.033 | 0.223 | Neurotrophic factor | 0.223 0.019 DBMET00800 0.223 0.019 DBMET00458 | DBMET00458 | |
| 0.17 | 0.014 | 0.17 | Opioid kappa receptor antagonist | 0.154 0.016 DBMET00800 0.154 0.016 DBMET00458 | ||
| 0.188 | 0.041 | 0.188 | Tubulin antagonist | |||
| 0.17 | 0.028 | 0.281 | Expectorant | 0.281 0.01 DBMET00800 0.281 0.01 DBMET00458 | DBMET00458 | |
| 0.305 | 0.168 | 0.305 | Apoptosis agonist | 0.29 0.179 DBMET00800 0.29 0.179 DBMET00458 | ||
| 0.156 | 0.026 | 0.202 | Antineoplastic alkaloid | 0.202 0.013 DBMET00800 0.202 0.013 DBMET00458 | DBMET00458 | |
| 0.159 | 0.031 | 0.165 | Vanilloid 1 agonist | 0.165 0.026 DBMET00800 0.165 0.026 DBMET00458 | DBMET00458 | |
| 0.179 | 0.057 | 0.179 | Cholinergic | 0.171 0.062 DBMET00800 0.171 0.062 DBMET00458 | ||
| 0.147 | 0.028 | 0.147 | Nav1.5 sodium channel blocker | |||
| 0.22 | 0.102 | 0.248 | Interleukin agonist | 0.248 0.08 DBMET00800 0.248 0.08 DBMET00458 | DBMET00458 | |
| 0.181 | 0.063 | 0.218 | Antipruritic | 0.218 0.038 DBMET00800 0.218 0.038 DBMET00458 | DBMET00458 | |
| 0.213 | 0.104 | 0.264 | DNA synthesis inhibitor | 0.264 0.058 DBMET00800 0.264 0.058 DBMET00458 | DBMET00458 | |
| 0.243 | 0.141 | 0.332 | Vasodilator, coronary | 0.332 0.065 DBMET00800 0.332 0.065 DBMET00458 | DBMET00458 | |
| 0.239 | 0.14 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 DBMET00800 0.321 0.061 DBMET00458 | DBMET00458 | |
| 0.128 | 0.031 | 0.138 | Acetylcholine M3 receptor agonist | 0.138 0.026 DBMET00800 0.138 0.026 DBMET00458 | DBMET00458 | |
| 0.125 | 0.028 | 0.185 | Acetylcholine nicotinic antagonist | 0.185 0.014 DBMET00800 0.185 0.014 DBMET00458 | DBMET00458 | |
| 0.14 | 0.043 | 0.181 | Microtubule formation inhibitor | 0.181 0.025 DBMET00800 0.181 0.025 DBMET00458 | DBMET00458 | |
| 0.114 | 0.019 | 0.114 | Beta tubulin antagonist | |||
| 0.14 | 0.046 | 0.14 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.206 | 0.111 | 0.206 | Superoxide dismutase inhibitor | 0.196 0.122 DBMET00800 0.196 0.122 DBMET00458 | ||
| 0.144 | 0.054 | 0.179 | Cyclooxygenase 3 inhibitor | 0.179 0.028 DBMET00800 0.179 0.028 DBMET00458 | DBMET00458 | |
| 0.119 | 0.03 | 0.119 | mTOR complex 1 inhibitor | |||
| 0.093 | 0.005 | 0.093 | Factor III inhibitor | 0.087 0.005 DBMET00800 0.087 0.005 DBMET00458 | ||
| 0.13 | 0.042 | 0.158 | Antiadrenergic | 0.158 0.034 DBMET00800 0.158 0.034 DBMET00458 | DBMET00458 | |
| 0.123 | 0.035 | 0.123 | Opioid antagonist | 0.123 0.035 DBMET00800 0.123 0.035 DBMET00458 | ||
| 0.194 | 0.11 | 0.289 | Vasodilator | 0.289 0.052 DBMET00800 0.289 0.052 DBMET00458 | DBMET00458 | |
| 0.124 | 0.042 | 0.15 | Adrenaline antagonist | 0.15 0.034 DBMET00800 0.15 0.034 DBMET00458 | DBMET00458 | |
| 0.102 | 0.021 | 0.102 | Ca(v)3.1 blocker | 0.086 0.044 DBMET00800 0.086 0.044 DBMET00458 | ||
| 0.116 | 0.038 | 0.181 | Alpha 2 adrenoreceptor antagonist | 0.181 0.021 DBMET00800 0.181 0.021 DBMET00458 | DBMET00458 | |
| 0.099 | 0.025 | 0.112 | Dopamine D1 antagonist | 0.112 0.022 DBMET00800 0.112 0.022 DBMET00458 | DBMET00458 | |
| 0.135 | 0.062 | 0.193 | Cholinergic antagonist | 0.193 0.034 DBMET00800 0.193 0.034 DBMET00458 | DBMET00458 | |
| 0.208 | 0.136 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.242 0.089 DBMET00800 0.242 0.089 DBMET00458 | DBMET00458 | |
| 0.141 | 0.07 | 0.141 | Cytokine production inhibitor | |||
| 0.132 | 0.061 | 0.188 | Acetylcholine antagonist | 0.188 0.034 DBMET00800 0.188 0.034 DBMET00458 | DBMET00458 | |
| 0.085 | 0.018 | 0.085 | Alpha tubulin antagonist | |||
| 0.22 | 0.154 | 0.34 | Antithrombotic | 0.34 0.068 DBMET00800 0.34 0.068 DBMET00458 | DBMET00458 | |
| 0.096 | 0.033 | 0.096 | Opioid mu receptor antagonist | 0.092 0.035 DBMET00800 0.092 0.035 DBMET00458 | ||
| 0.145 | 0.085 | 0.171 | Interferon gamma antagonist | 0.171 0.056 DBMET00800 0.171 0.056 DBMET00458 | DBMET00458 | |
| 0.088 | 0.03 | 0.113 | Neuronal nicotinic receptor antagonist | 0.113 0.02 DBMET00800 0.113 0.02 DBMET00458 | DBMET00458 | |
| 0.08 | 0.024 | 0.084 | Androgen agonist | 0.084 0.022 DBMET00800 0.084 0.022 DBMET00458 | DBMET00458 | |
| 0.073 | 0.017 | 0.075 | Prolactin release inhibitor | 0.075 0.015 DBMET00800 0.075 0.015 DBMET00458 | DBMET00458 | |
| 0.071 | 0.015 | 0.071 | Dopamine D5 antagonist | 0.07 0.015 DBMET00800 0.07 0.015 DBMET00458 | ||
| 0.229 | 0.173 | 0.229 | Histamine release inhibitor | 0.215 0.185 DBMET00800 0.215 0.185 DBMET00458 | ||
| 0.069 | 0.015 | 0.069 | Opioid kappa receptor agonist | 0.063 0.017 DBMET00800 0.063 0.017 DBMET00458 | ||
| 0.101 | 0.047 | 0.101 | Calcium antagonist | |||
| 0.06 | 0.007 | 0.06 | Catechol O-methyltransferase inhibitor | |||
| 0.165 | 0.117 | 0.194 | Neurotrophic factor enhancer | 0.194 0.082 DBMET00800 0.194 0.082 DBMET00458 | DBMET00458 | |
| 0.087 | 0.043 | 0.087 | CC chemokine 5 receptor agonist | 0.082 0.057 DBMET00800 0.082 0.057 DBMET00458 | ||
| 0.076 | 0.031 | 0.076 | 5 Hydroxytryptamine 2A agonist | 0.069 0.038 DBMET00800 0.069 0.038 DBMET00458 | ||
| 0.108 | 0.065 | 0.108 | Electron transport complex I inhibitor | 0.103 0.077 DBMET00800 0.103 0.077 DBMET00458 | ||
| 0.268 | 0.231 | 0.372 | Caspase 9 stimulant | 0.372 0.129 DBMET00800 0.372 0.129 DBMET00458 | DBMET00458 | |
| 0.11 | 0.078 | 0.142 | Acetylcholine muscarinic antagonist | 0.142 0.048 DBMET00800 0.142 0.048 DBMET00458 | DBMET00458 | |
| 0.052 | 0.019 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET00800 0.062 0.01 DBMET00458 | DBMET00458 | |
| 0.092 | 0.062 | 0.106 | Alpha adrenoreceptor antagonist | 0.106 0.053 DBMET00800 0.106 0.053 DBMET00458 | DBMET00458 | |
| 0.077 | 0.049 | 0.097 | Dopamine antagonist | 0.097 0.04 DBMET00800 0.097 0.04 DBMET00458 | DBMET00458 | |
| 0.075 | 0.046 | 0.111 | Glycine receptor agonist | 0.111 0.015 DBMET00800 0.111 0.015 DBMET00458 | DBMET00458 | |
| 0.058 | 0.031 | 0.059 | Acetylcholine M2 receptor agonist | 0.059 0.03 DBMET00800 0.059 0.03 DBMET00458 | DBMET00458 | |
| 0.035 | 0.009 | 0.035 | Estrone sulfatase inhibitor | |||
| 0.038 | 0.013 | 0.041 | Complement C5a chemotactic receptor antagonist | 0.041 0.012 DBMET00800 0.041 0.012 DBMET00458 | DBMET00458 | |
| 0.094 | 0.071 | 0.149 | Alpha 2c adrenoreceptor antagonist | 0.149 0.032 DBMET00800 0.149 0.032 DBMET00458 | DBMET00458 | |
| 0.125 | 0.102 | 0.191 | Acetylcholine M1 receptor antagonist | 0.191 0.046 DBMET00800 0.191 0.046 DBMET00458 | DBMET00458 | |
| 0.055 | 0.034 | 0.055 | Opioid agonist | 0.052 0.038 DBMET00800 0.052 0.038 DBMET00458 | ||
| 0.134 | 0.114 | 0.157 | Nitric oxide antagonist | 0.157 0.089 DBMET00800 0.157 0.089 DBMET00458 | DBMET00458 | |
| 0.052 | 0.033 | 0.052 | Sigma receptor antagonist | |||
| 0.058 | 0.04 | 0.084 | Dopamine uptake inhibitor | 0.084 0.024 DBMET00800 0.084 0.024 DBMET00458 | DBMET00458 | |
| 0.073 | 0.055 | 0.116 | Alpha 2a adrenoreceptor antagonist | 0.116 0.03 DBMET00800 0.116 0.03 DBMET00458 | DBMET00458 | |
| 0.212 | 0.196 | 0.225 | Calcium channel activator | 0.225 0.178 DBMET00800 0.225 0.178 DBMET00458 | DBMET00458 | |
| 0.074 | 0.057 | 0.105 | Nicotinic alpha4beta2 receptor antagonist | 0.105 0.028 DBMET00800 0.105 0.028 DBMET00458 | DBMET00458 | |
| 0.04 | 0.024 | 0.04 | 5 Hydroxytryptamine 2B agonist | |||
| 0.065 | 0.05 | 0.065 | Acetylcholine M5 receptor agonist | |||
| 0.142 | 0.129 | 0.142 | Antimitotic | |||
| 0.064 | 0.051 | 0.064 | Toll-Like receptor 7 antagonist | |||
| 0.024 | 0.012 | 0.024 | Nociceptin (N/OFQ) receptor agonist | 0.022 0.014 DBMET00800 0.022 0.014 DBMET00458 | ||
| 0.088 | 0.076 | 0.164 | Bronchodilator | 0.164 0.027 DBMET00800 0.164 0.027 DBMET00458 | DBMET00458 | |
| 0.184 | 0.173 | 0.184 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.052 | 0.041 | 0.063 | Nicotinic receptor alpha7 subunit antagonist | 0.063 0.026 DBMET00800 0.063 0.026 DBMET00458 | DBMET00458 | |
| 0.015 | 0.005 | 0.015 | Melatonin 2 antagonist | |||
| 0.114 | 0.105 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.105 | 0.097 | 0.105 | Acetylcholinesterase inhibitor | |||
| 0.05 | 0.043 | 0.055 | Acetylcholine muscarinic agonist | 0.055 0.038 DBMET00800 0.055 0.038 DBMET00458 | DBMET00458 | |
| 0.013 | 0.006 | 0.013 | Calcineurin inhibitor | 0.012 0.007 DBMET00800 0.012 0.007 DBMET00458 | ||
| 0.044 | 0.038 | 0.091 | Dopamine transporter inhibitor | 0.091 0.014 DBMET00800 0.091 0.014 DBMET00458 | DBMET00458 | |
| 0.031 | 0.025 | 0.031 | Melatonin agonist | |||
| 0.056 | 0.052 | 0.056 | Dopamine D2 antagonist | |||
| 0.033 | 0.03 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.053 | 0.051 | 0.053 | Opioid delta receptor antagonist | |||
| 0.027 | 0.026 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.062 | 0.06 | 0.062 | Glutamate (mGluR7) antagonist | |||
| 0.067 | 0.066 | 0.078 | Analgesic, opioid | 0.078 0.05 DBMET00800 0.078 0.05 DBMET00458 | DBMET00458 | |
| 0.053 | 0.054 | 0.114 | 5 Hydroxytryptamine uptake inhibitor | 0.114 0.022 DBMET00800 0.114 0.022 DBMET00458 | DBMET00458 | |
| 0.128 | 0.13 | 0.166 | Tumour necrosis factor antagonist | 0.166 0.081 DBMET00800 0.166 0.081 DBMET00458 | DBMET00458 | |
| 0.048 | 0.05 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.025 DBMET00800 0.061 0.025 DBMET00458 | DBMET00458 | |
| 0.079 | 0.081 | 0.113 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 DBMET00800 0.113 0.025 DBMET00458 | DBMET00458 | |
| 0.02 | 0.023 | 0.022 | Dopamine D1 agonist | 0.022 0.018 DBMET00800 0.022 0.018 DBMET00458 | DBMET00458 | |
| 0.048 | 0.051 | 0.062 | Dopamine D4 antagonist | 0.062 0.041 DBMET00800 0.062 0.041 DBMET00458 | DBMET00458 | |
| 0.052 | 0.056 | 0.065 | Acetylcholine M5 receptor antagonist | 0.065 0.035 DBMET00800 0.065 0.035 DBMET00458 | DBMET00458 | |
| 0.12 | 0.125 | 0.164 | Adenylate cyclase stimulant | 0.164 0.042 DBMET00800 0.164 0.042 DBMET00458 | DBMET00458 | |
| 0.106 | 0.111 | 0.148 | Protein kinase stimulant | 0.148 0.07 DBMET00800 0.148 0.07 DBMET00458 | DBMET00458 | |
| 0.089 | 0.095 | 0.141 | Mucolytic | 0.141 0.038 DBMET00800 0.141 0.038 DBMET00458 | DBMET00458 | |
| 0.048 | 0.063 | 0.06 | Alpha 2 adrenoreceptor agonist | 0.06 0.043 DBMET00800 0.06 0.043 DBMET00458 | DBMET00458 | |
| 0.081 | 0.098 | 0.129 | Alpha 2b adrenoreceptor antagonist | 0.129 0.051 DBMET00800 0.129 0.051 DBMET00458 | DBMET00458 | |
| 0.056 | 0.079 | 0.077 | Acetylcholine M4 receptor antagonist | 0.077 0.05 DBMET00800 0.077 0.05 DBMET00458 | DBMET00458 | |
| 0.132 | 0.158 | 0.154 | Aldehyde oxidase inhibitor | 0.154 0.135 DBMET00800 0.154 0.135 DBMET00458 | DBMET00458 | |
| 0.121 | 0.149 | 0.187 | Hepatoprotectant | 0.187 0.074 DBMET00800 0.187 0.074 DBMET00458 | DBMET00458 | |
| 0.062 | 0.094 | 0.089 | Glycine receptor antagonist | 0.089 0.044 DBMET00800 0.089 0.044 DBMET00458 | DBMET00458 | |
| 0.05 | 0.083 | 0.073 | Antineoplastic antibiotic | 0.073 0.062 DBMET00800 0.073 0.062 DBMET00458 | DBMET00458 | |
| 0.039 | 0.072 | 0.054 | Acetylcholine M2 receptor antagonist | 0.054 0.05 DBMET00800 0.054 0.05 DBMET00458 | DBMET00458 | |
| 0.123 | 0.157 | 0.153 | Lipocortins synthesis antagonist | 0.153 0.1 DBMET00800 0.153 0.1 DBMET00458 | DBMET00458 | |
| 0.017 | 0.057 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 DBMET00800 0.041 0.012 DBMET00458 | DBMET00458 | |
| 0.019 | 0.06 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 DBMET00800 0.033 0.009 DBMET00458 | DBMET00458 | |
| 0.198 | 0.24 | 0.227 | Analgesic | 0.227 0.206 DBMET00800 0.227 0.206 DBMET00458 | DBMET00458 | |
| 0.038 | 0.081 | 0.05 | Antiviral (Hepatitis D) | 0.05 0.037 DBMET00800 0.05 0.037 DBMET00458 | DBMET00458 | |
| 0.069 | 0.114 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET00800 0.079 0.069 DBMET00458 | DBMET00458 | |
| 0.04 | 0.09 | 0.073 | Adrenaline uptake inhibitor | 0.073 0.032 DBMET00800 0.073 0.032 DBMET00458 | DBMET00458 | |
| 0.075 | 0.128 | 0.093 | Nav1.4 sodium channel blocker | 0.093 0.088 DBMET00800 0.093 0.088 DBMET00458 | DBMET00458 | |
| 0.101 | 0.157 | 0.145 | Arachidonic acid antagonist | 0.145 0.094 DBMET00800 0.145 0.094 DBMET00458 | DBMET00458 | |
| 0.028 | 0.086 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET00800 0.048 0.042 DBMET00458 | DBMET00458 | |
| 0.045 | 0.108 | 0.057 | Lipocortins synthesis agonist | 0.057 0.041 DBMET00800 0.057 0.041 DBMET00458 | DBMET00458 | |
| 0.022 | 0.088 | 0.033 | Tubulin agonist | 0.033 0.027 DBMET00800 0.033 0.027 DBMET00458 | DBMET00458 | |
| 0.024 | 0.105 | 0.058 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET00800 0.058 0.043 DBMET00458 | DBMET00458 | |
| 0.112 | 0.196 | 0.151 | ATPase inhibitor | 0.151 0.1 DBMET00800 0.151 0.1 DBMET00458 | DBMET00458 | |
| 0.063 | 0.152 | 0.117 | Cholesterol synthesis inhibitor | 0.117 0.068 DBMET00800 0.117 0.068 DBMET00458 | DBMET00458 | |
| 0.068 | 0.16 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.063 DBMET00800 0.104 0.063 DBMET00458 | DBMET00458 | |
| 0.07 | 0.164 | 0.132 | Alpha-N-acetylglucosaminidase inhibitor | 0.132 0.067 DBMET00800 0.132 0.067 DBMET00458 | DBMET00458 | |
| 0.096 | 0.198 | 0.139 | Melanin inhibitor | 0.139 0.097 DBMET00800 0.139 0.097 DBMET00458 | DBMET00458 | |
| 0.005 | 0.109 | 0.016 | Prostacyclin agonist | 0.016 0.011 DBMET00800 0.016 0.011 DBMET00458 | DBMET00458 | |
| 0.069 | 0.177 | 0.11 | Lipid peroxidase inhibitor | 0.11 0.105 DBMET00800 0.11 0.105 DBMET00458 | DBMET00458 | |
| 0.052 | 0.162 | 0.116 | Anesthetic local | 0.116 0.07 DBMET00800 0.116 0.07 DBMET00458 | DBMET00458 | |
| 0.103 | 0.216 | 0.214 | Platelet antagonist | 0.214 0.092 DBMET00800 0.214 0.092 DBMET00458 | DBMET00458 | |
| 0.065 | 0.188 | 0.135 | Thrombolytic | 0.135 0.094 DBMET00800 0.135 0.094 DBMET00458 | DBMET00458 | |
| 0.094 | 0.233 | 0.177 | Immunostimulant | 0.177 0.135 DBMET00800 0.177 0.135 DBMET00458 | DBMET00458 | |
| 0.142 | 0.293 | 0.209 | Apoptosis antagonist | 0.209 0.168 DBMET00800 0.209 0.168 DBMET00458 | DBMET00458 | |
| 0.096 | 0.292 | 0.167 | Hypoglycemic | 0.167 0.152 DBMET00800 0.167 0.152 DBMET00458 | DBMET00458 | |
| 0.062 | 0.386 | 0.172 | Cardiotonic | 0.172 0.149 DBMET00800 0.172 0.149 DBMET00458 | DBMET00458 | |
| 0.054 | 0.55 | 0.4 | Toll-Like receptor 7 agonist | 0.4 0.06 DBMET00800 0.4 0.06 DBMET00458 | DBMET00458 | |
| 0.05 | 0.561 | 0.395 | Toll-Like receptor agonist | 0.395 0.062 DBMET00800 0.395 0.062 DBMET00458 | DBMET00458 | |
| 0.053 | 0.626 | 0.313 | Cyclophilin D inhibitor | 0.313 0.151 DBMET00800 0.313 0.151 DBMET00458 | DBMET00458 | |
| 0.011 | 0.612 | 0.072 | Prostaglandin F2 alpha antagonist | 0.072 0.03 DBMET00800 0.072 0.03 DBMET00458 | DBMET00458 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |